SCHOTT Begins RTF Syringe Production in U.S.

SCHOTT’s Pharmaceutical Packaging business began production of ready-to-fill glass syringes at its manufacturing facility in Lebanon, PA. The company has invested more than $14 million in the new production capability, and will add 40 new jobs during the next year.

Syringe production capability at the 170,000-sq.-ft. plant will be 270,000 units per day. The company will move to 24-hour production within the next two years. With the addition of ready-to-fill syringes, all of SCHOTT’s pharmaceutical packaging products, which include vials, ampoules and cartridges, will now be produced in North America. SCHOTT will be the second company to produce ready-to-fill syringes in the U.S.

“We hope to increase the market share of domestically produced ready-to-fills, once we are fully operational here in Lebanon,” said Renard Jackson, Vice President of SCHOTT North America, Inc. and General Manager of its Pharmaceutical Packaging Division. “We’re delivering the same high quality standards our customers have come to expect.”

The company plans to further invest $30 million in the Lebanon facility in the future, and potentially employ 80 additional people.